临床合理用药杂志
臨床閤理用藥雜誌
림상합리용약잡지
CHINESE JOURNAL OF CLINICAL RATIONAL DRUG USE
2014年
12期
11-11,13
,共2页
米非司酮%米索前列醇%流产,合法%可行性研究
米非司酮%米索前列醇%流產,閤法%可行性研究
미비사동%미색전렬순%유산,합법%가행성연구
Mifepristone%Misoprostol%Abortion,legal%Feasibility studies
目的:探讨米非司酮配伍米索前列醇用于12~16周药物流产的可行性。方法选取本院2O11年8月-2O13年8月收治的86例自愿终止妊娠者,随机将其分为对照组与观察组,各43例。对照组给予宫腔放管后钳刮术,观察组给予米非司酮配伍米索前列醇,比较两组流产效果。结果观察组妊娠者疼痛情况轻于对照组,差异有统计学意义(P < O. O5)。观察组出血量、流产失败率与再孕流产率均低于对照组,差异有统计学意义( P < O. O5)。结论采用米非司酮配伍米索前列醇用于12~16周药物流产妊娠者具有更优的安全性与可行性,值得临床推广应用。
目的:探討米非司酮配伍米索前列醇用于12~16週藥物流產的可行性。方法選取本院2O11年8月-2O13年8月收治的86例自願終止妊娠者,隨機將其分為對照組與觀察組,各43例。對照組給予宮腔放管後鉗颳術,觀察組給予米非司酮配伍米索前列醇,比較兩組流產效果。結果觀察組妊娠者疼痛情況輕于對照組,差異有統計學意義(P < O. O5)。觀察組齣血量、流產失敗率與再孕流產率均低于對照組,差異有統計學意義( P < O. O5)。結論採用米非司酮配伍米索前列醇用于12~16週藥物流產妊娠者具有更優的安全性與可行性,值得臨床推廣應用。
목적:탐토미비사동배오미색전렬순용우12~16주약물유산적가행성。방법선취본원2O11년8월-2O13년8월수치적86례자원종지임신자,수궤장기분위대조조여관찰조,각43례。대조조급여궁강방관후겸괄술,관찰조급여미비사동배오미색전렬순,비교량조유산효과。결과관찰조임신자동통정황경우대조조,차이유통계학의의(P < O. O5)。관찰조출혈량、유산실패솔여재잉유산솔균저우대조조,차이유통계학의의( P < O. O5)。결론채용미비사동배오미색전렬순용우12~16주약물유산임신자구유경우적안전성여가행성,치득림상추엄응용。
Objective To investigate the feasibility of Mifepristone and Misoprostol used in 12 - 16 weeks pregnant woman for drug abortion. Methods 86 cases of voluntary termination pregnancy in this hospital from August 2O11 to August 2O13,were randomly divided into control group and observation group,43 cases of each group. Control group was given the pal-ace cavity tube after curettage,observation group was given Mifepristone and Misoprostol,abortion effects were compared be-tween the two groups. Results The pain of observation group was lighter than control group,the difference was statistically sig-nificant(P < O. O5). Amount of bleeding,abortion failure rate and pregnancy abortion rate of observation group was lower than control group,the difference was statistically significant(P < O. O5). Conclusion The use of mifepristone combined with mi-soprostol for medical abortion in 12 - 16 weeks pregnancy is safe and feasible better,is worthy of clinical application.